Indipil T Tablet SR is a combination antihypertensive medication containing Telmisartan 40 mg and Indapamide 1.5 mg, formulated to provide sustained-release action for effective blood pressure control. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby preventing vasoconstriction and aldosterone secretion, resulting in vasodilation and reduced blood pressure. Indapamide, a thiazide-like diuretic, promotes natriuresis and diuresis by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, reducing plasma volume and peripheral resistance. The combination of these two agents offers complementary mechanisms that enhance antihypertensive efficacy while minimizing electrolyte imbalances commonly associated with diuretics alone. Indipil T Tablet SR is indicated for the management of essential hypertension, particularly in patients who require dual therapy to achieve target blood pressure levels. The sustained-release formulation ensures a gradual and prolonged drug release, improving patient compliance and maintaining stable plasma concentrations throughout the dosing interval. This medication should be used under medical supervision with regular monitoring of blood pressure, renal function, and electrolytes to optimize therapeutic outcomes and minimize potential adverse effects.